D. Ayalon

716 total citations
29 papers, 598 citations indexed

About

D. Ayalon is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, D. Ayalon has authored 29 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in D. Ayalon's work include Reproductive Biology and Fertility (4 papers), Ovarian function and disorders (3 papers) and Cannabis and Cannabinoid Research (3 papers). D. Ayalon is often cited by papers focused on Reproductive Biology and Fertility (4 papers), Ovarian function and disorders (3 papers) and Cannabis and Cannabinoid Research (3 papers). D. Ayalon collaborates with scholars based in Israel, Belgium and Switzerland. D. Ayalon's co-authors include T. CORDOVA, H.R. Lindner, Zvi Naor, Rona Limor, A. Tsafriri, Alessandro M. Capponi, I. Nir, A. Harell, Eli Hazum and Michel F. Rossier and has published in prestigious journals such as Nature, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

In The Last Decade

D. Ayalon

28 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Ayalon Israel 12 234 161 149 138 132 29 598
D D Nansel United States 16 214 0.9× 34 0.2× 229 1.5× 94 0.7× 112 0.8× 23 638
Winfried G. Rossmanith Germany 18 467 2.0× 256 1.6× 189 1.3× 25 0.2× 104 0.8× 55 822
K Kurachi Japan 17 281 1.2× 125 0.8× 304 2.0× 13 0.1× 115 0.9× 51 883
Tomasz Ochędalski Poland 18 74 0.3× 118 0.7× 228 1.5× 39 0.3× 179 1.4× 43 990
Anselmo Palacios Venezuela 13 128 0.5× 46 0.3× 325 2.2× 47 0.3× 144 1.1× 21 529
David R. Hole United Kingdom 13 261 1.1× 162 1.0× 103 0.7× 12 0.1× 87 0.7× 17 585
N. -O. Sj�berg Sweden 13 190 0.8× 76 0.5× 82 0.6× 26 0.2× 227 1.7× 14 873
Julie K. Crone United States 12 159 0.7× 53 0.3× 533 3.6× 62 0.4× 153 1.2× 12 974
L Devilla Italy 15 141 0.6× 38 0.2× 308 2.1× 21 0.2× 93 0.7× 43 590
Y Yaoi Japan 12 96 0.4× 80 0.5× 335 2.2× 27 0.2× 66 0.5× 35 676

Countries citing papers authored by D. Ayalon

Since Specialization
Citations

This map shows the geographic impact of D. Ayalon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Ayalon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Ayalon more than expected).

Fields of papers citing papers by D. Ayalon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Ayalon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Ayalon. The network helps show where D. Ayalon may publish in the future.

Co-authorship network of co-authors of D. Ayalon

This figure shows the co-authorship network connecting the top 25 collaborators of D. Ayalon. A scholar is included among the top collaborators of D. Ayalon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Ayalon. D. Ayalon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Razon, N., et al.. (1997). Programmable classification of pituitary adenomas. Clinical Neurology and Neurosurgery. 99. S92–S92. 4 indexed citations
2.
Barnard, Geoff, et al.. (1995). The measurement of progesterone in serum by a non-competitive idiometric assay. Steroids. 60(12). 824–829. 24 indexed citations
3.
Eckstein, Nachman, J. Földes, R. Steinberg, et al.. (1992). Calcium homeostasis, bone metabolism and safety aspects during long-term treatment with a GnRH agonist. Maturitas. 15(1). 25–32. 6 indexed citations
4.
Ayalon, D., et al.. (1992). Effects of Long Term Treatment With Finasteride (MK-906), a 5-Alpha Reductase Inhibitor, on Circulating LH, FSH, Prolactin and Estradiol. Hormone and Metabolic Research. 24(10). 498–499. 11 indexed citations
5.
Limor, Rona, Iris Schvartz, Eli Hazum, D. Ayalon, & Zvi Naor. (1989). Effect of guanine nucleotides on phospholipase C activity in permeabilized pituitary cells: Possible involvement of an inhibitory GTP-binding protein. Biochemical and Biophysical Research Communications. 159(1). 209–215. 22 indexed citations
6.
Dekel, Nava, et al.. (1988). RECEPTORS FOR GONADOTROPIN RELEASING HORMONE ARE PRESENT IN RAT OOCYTES. Endocrinology. 123(2). 1205–1207. 44 indexed citations
7.
Naor, Zvi, Alessandro M. Capponi, Michel F. Rossier, D. Ayalon, & Rona Limor. (1988). Gonadotropin-Releasing Hormone- Induced Rise in Cytosolic Free Ca2+Levels: Mobilization of Cellular and Extracellular Ca2+Pools and Relationship to Gonadotropin Secretion. Molecular Endocrinology. 2(6). 512–520. 70 indexed citations
8.
Limor, Rona, D. Ayalon, Alessandro M. Capponi, Gwen V. Childs, & Zvi Naor. (1987). Cytosolic Free Calcium Levels in Cultured Pituitary Cells Separated by Centrifugal Elutriation: Effect of Gonadotropin-Releasing Hormone*. Endocrinology. 120(2). 497–503. 61 indexed citations
9.
Peleg, Leah, et al.. (1986). Improved reliability of a serum alpha-fetoprotein enzyme immunoassay compared with a radioimmunoassay.. PubMed. 22(3-4). 215–9. 1 indexed citations
10.
Chitayat, David, Z Spirer, D. Ayalon, & Avraham Golander. (1985). Pseudohypoaldosteronism in a Female Infant and Her Family: Diversity of Clinical Expression and Mode of Inheritance. Acta Paediatrica. 74(4). 619–622. 16 indexed citations
11.
Córdova–Fraga, Teodoro, et al.. (1984). The Suppressive Effect of Delta-1-Tetrahydrocannabinol on the Steroidogenic Activity of Rat Granulosa Cells in Culture. Hormone Research. 19(1). 43–51. 8 indexed citations
12.
Vardi, J., et al.. (1983). Prostaglandin ‐ E 2 Levels in the Saliva of Common Migrainous Women. Headache The Journal of Head and Face Pain. 23(2). 59–61. 18 indexed citations
13.
Ayalon, D., Nachman Eckstein, M. L’Hermite, et al.. (1983). Dopaminergic Regulation of Prolactin Secretion in the Hyperprolactinemic Syndrome. Gynecologic and Obstetric Investigation. 16(2). 97–106. 1 indexed citations
14.
Ayalon, D., et al.. (1981). Failure of naloxone to antagonize metoclopramide induced prolactin rise. Journal of Neural Transmission. 52(1-2). 49–54. 7 indexed citations
15.
16.
Ayalon, D., et al.. (1974). Effect of L-dopa on galactopoiesis and gonadotropin levels in the inappropriate lactation syndrome.. PubMed. 44(2). 159–70. 3 indexed citations
17.
Nir, I., D. Ayalon, A. Tsafriri, T. CORDOVA, & H.R. Lindner. (1973). Suppression of the Cyclic Surge of Luteinizing Hormone Secretion and of Ovulation in the Rat by Δ1-Tetrahydrocannabinol. Nature. 243(5408). 470–471. 76 indexed citations
18.
Ayalon, D., A. Tsafriri, H.R. Lindner, T. CORDOVA, & A. Harell. (1972). SERUM GONADOTROPHIN LEVELS IN PRO-OESTROUS RATS IN RELATION TO THE RESUMPTION OF MEIOSIS BY THE OOCYTES. Reproduction. 31(1). 51–58. 77 indexed citations
19.
Toaff, R, et al.. (1971). Clinical use of high concentration oxytocin drip.. PubMed. 37(1). 112–20. 6 indexed citations
20.
Toaff, R, D. Ayalon, Bruno Lunenfeld, & Aliza Eshkol. (1965). IMMUNO‐TITRATIONS AND QUANTITATIVE BIOASSAYS OF PREGNANCY URINE. BJOG An International Journal of Obstetrics & Gynaecology. 72(2). 236–241. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D D Nansel Breakdown of academic impact, for papers by Winfried G. Rossmanith Breakdown of academic impact, for papers by K Kurachi Breakdown of academic impact, for papers by Tomasz Ochędalski Breakdown of academic impact, for papers by Anselmo Palacios Breakdown of academic impact, for papers by David R. Hole Breakdown of academic impact, for papers by N. -O. Sj�berg Breakdown of academic impact, for papers by Julie K. Crone Breakdown of academic impact, for papers by L Devilla Breakdown of academic impact, for papers by Y Yaoi
Rankless by CCL
2026